SLC1A4
Basic information
Region (hg38): 2:64988477-65023865
Links
Phenotypes
GenCC
Source:
- spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome (Strong), mode of inheritance: AR
- spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome (Supportive), mode of inheritance: AR
- spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spastic tetraplegia, thin corpus callosum, and progressive microcephaly | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 25930971; 26041762; 26138499; 29989513; 31763347 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (10 variants)
- Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC1A4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 180 | 186 | ||||
missense | 83 | 94 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 8 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 2 | 9 | 11 | |||
non coding | 39 | 16 | 56 | |||
Total | 11 | 9 | 86 | 223 | 25 |
Highest pathogenic variant AF is 0.000105
Variants in SLC1A4
This is a list of pathogenic ClinVar variants found in the SLC1A4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-64989247-TC-T | Benign (May 15, 2021) | |||
2-64989251-GGCGGCGGCTCCC-G | Benign (May 14, 2021) | |||
2-64989311-C-G | Benign (May 20, 2021) | |||
2-64989353-T-C | Benign (May 14, 2021) | |||
2-64989513-C-G | Benign (May 14, 2021) | |||
2-64989514-G-C | Benign (May 14, 2021) | |||
2-64989609-C-T | Benign (May 16, 2021) | |||
2-64989643-C-T | Uncertain significance (Dec 01, 2018) | |||
2-64989645-T-C | Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome | Pathogenic (Mar 01, 2023) | ||
2-64989664-C-A | Benign (Jan 31, 2024) | |||
2-64989679-C-T | Likely benign (Jan 20, 2024) | |||
2-64989683-G-A | Benign/Likely benign (Jul 01, 2024) | |||
2-64989685-T-C | SLC1A4-related disorder | Likely benign (Jan 23, 2023) | ||
2-64989691-G-A | Likely benign (Jun 01, 2024) | |||
2-64989691-G-T | Likely benign (Dec 30, 2023) | |||
2-64989692-G-A | Uncertain significance (May 12, 2022) | |||
2-64989694-G-A | Likely benign (Jan 19, 2024) | |||
2-64989694-G-T | Likely benign (Jan 05, 2023) | |||
2-64989703-C-A | Likely benign (Feb 09, 2023) | |||
2-64989703-C-T | Likely benign (Oct 14, 2023) | |||
2-64989706-G-C | Likely benign (Sep 28, 2023) | |||
2-64989708-C-A | Uncertain significance (Feb 19, 2022) | |||
2-64989708-C-T | SLC1A4-related disorder | Conflicting classifications of pathogenicity (Jan 31, 2024) | ||
2-64989709-C-T | Likely benign (Nov 06, 2023) | |||
2-64989711-G-A | Uncertain significance (Aug 09, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC1A4 | protein_coding | protein_coding | ENST00000234256 | 8 | 35389 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0656 | 0.932 | 125718 | 0 | 29 | 125747 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.73 | 219 | 304 | 0.721 | 0.0000165 | 3366 |
Missense in Polyphen | 121 | 166.48 | 0.72681 | 1859 | ||
Synonymous | 0.486 | 128 | 135 | 0.947 | 0.00000812 | 1179 |
Loss of Function | 2.62 | 5 | 16.5 | 0.303 | 7.99e-7 | 200 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000194 | 0.000193 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Transporter for alanine, serine, cysteine, and threonine. Exhibits sodium dependence. {ECO:0000269|PubMed:26041762}.;
- Pathway
- Argininemia;Citrullinemia Type I;Carbamoyl Phosphate Synthetase Deficiency;Argininosuccinic Aciduria;Glucose-Alanine Cycle;Urea Cycle;Glutaminolysis and Cancer;Ornithine Transcarbamylase Deficiency (OTC Deficiency);miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Tyrosine metabolism;Amino acid transport across the plasma membrane;Amino acid and oligopeptide SLC transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Histidine metabolism;Methionine and cysteine metabolism;Glycerophospholipid metabolism;Porphyrin metabolism;Glycine, serine, alanine and threonine metabolism
(Consensus)
Recessive Scores
- pRec
- 0.173
Intolerance Scores
- loftool
- 0.519
- rvis_EVS
- -0.11
- rvis_percentile_EVS
- 45.36
Haploinsufficiency Scores
- pHI
- 0.127
- hipred
- Y
- hipred_score
- 0.662
- ghis
- 0.472
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.618
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc1a4
- Phenotype
Gene ontology
- Biological process
- amino acid transport;glutamine transport;L-alanine transport;L-cystine transport;proline transport;L-serine transport;threonine transport;hydroxyproline transport;synaptic transmission, glutamatergic;proline transmembrane transport;cognition;chloride transmembrane transport
- Cellular component
- centrosome;microtubule organizing center;intermediate filament;plasma membrane;integral component of plasma membrane;cell surface;membrane;integral component of membrane;dendrite;melanosome;neuronal cell body;extracellular exosome
- Molecular function
- chloride channel activity;amino acid transmembrane transporter activity;L-alanine transmembrane transporter activity;L-cystine transmembrane transporter activity;L-glutamine transmembrane transporter activity;L-proline transmembrane transporter activity;L-serine transmembrane transporter activity;L-threonine transmembrane transporter activity;symporter activity;L-hydroxyproline transmembrane transporter activity